PABAF (Patrys) Accounts Payable: $0.35 Mil (As of Dec. 2025)


What is Patrys Accounts Payable?

Patrys PABAF Accounts Payable is $0.35 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Patrys's Accounts Payable for the quarter that ended in Dec. 2025 was $0.35 Mil.

Patrys's quarterly Accounts Payable declined from Dec. 2024 ($0.65 Mil) to Jun. 2025 ($0.09 Mil) but then increased from Jun. 2025 ($0.09 Mil) to Dec. 2025 ($0.35 Mil).

Patrys's annual Accounts Payable declined from Jun. 2023 ($0.20 Mil) to Jun. 2024 ($0.16 Mil) and declined from Jun. 2024 ($0.16 Mil) to Jun. 2025 ($0.09 Mil).

Patrys Accounts Payable Historical Data

* Premium members only.

The historical data trend for Patrys's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Patrys Accounts Payable Chart

Patrys Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.23 0.11 0.20 0.16 0.09

Patrys Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.16 0.65 0.09 0.35

Patrys Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.35 Mil mean?
Patrys (PABAF) has a Accounts Payable of $0.35 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Patrys and its competitors.
Is Patrys' Accounts Payable too high?
Patrys' current Accounts Payable is $0.35 Mil.
How does Patrys' Accounts Payable compare to VRTX and REGN?
Patrys' Accounts Payable of $0.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Patrys and its competitors. Patrys's current Accounts Payable is $0.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patrys stock overvalued right now?
Patrys (PABAF) has a current Accounts Payable of $0.35 Mil. The current Accounts Payable is $0.35 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Patrys (PABAF), the current Accounts Payable is $0.35 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Patrys Business Description

Other Exchanges PABDA:Australia
Address 385 Bourke Street, Suite 2, Level 11, Melbourne, VIC, AUS, 3000
Patrys Ltd is a biopharmaceutical company focused on developing novel antibody-based therapies prominently for cancer and related inflammatory diseases. Its core technology platform involves antibodies that penetrate cell nuclei and inhibit cancer cell DNA repair mechanisms. The company advances therapeutic candidates from its antibody platforms, including ones licensed from Yale University, with ongoing preclinical and clinical development activities. Patrys generates revenue through licensing agreements and collaborations linked to its antibody technologies. Its operations and development efforts span Australia and the United States.